These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid. Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025 [TBL] [Abstract][Full Text] [Related]
4. [Factors modulating production of antibodies against Clostridium perfringens in mammals]. Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303 [TBL] [Abstract][Full Text] [Related]
5. [Isolation of a purified theta-hemolysin from C1. perfingens type A and its use for titrating toxins and sera]. Efimova MG Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):40-3. PubMed ID: 6295033 [TBL] [Abstract][Full Text] [Related]
6. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens]. Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354 [TBL] [Abstract][Full Text] [Related]
8. [Characteristics of the immunologic response of animals to Clostridium perfringens anatoxin]. Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Vlasova EV Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):71-4. PubMed ID: 197752 [TBL] [Abstract][Full Text] [Related]
9. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A. Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638 [No Abstract] [Full Text] [Related]
10. [Preparation and evaluation of immunogenic properties of Clostridium perfringens type A toxoid]. Rymkiewicz D; Sawicki J; Brühl A; Sochańska R Med Dosw Mikrobiol; 1979; 31(2):95-102. PubMed ID: 228130 [No Abstract] [Full Text] [Related]
11. Alpha toxoid of Clostridium perfringens. II. Immunogenicity of the toxoid. Ito A Jpn J Med Sci Biol; 1970 Feb; 23(1):21-30. PubMed ID: 4317538 [No Abstract] [Full Text] [Related]
15. Protective effects of clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs. Amimoto K; Oishi E; Yasuhar H; Sasak O; Katayama S; Kitajima T; Izumida A; Hirahara T J Vet Med Sci; 2001 Aug; 63(8):879-83. PubMed ID: 11558543 [TBL] [Abstract][Full Text] [Related]
16. [Use of membrane separation methods in the production of Clostridium perfringens toxoid]. Semenova VD; Nikolaeva AM; Efimova NP Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):32-6. PubMed ID: 9662794 [TBL] [Abstract][Full Text] [Related]
17. [Study of the interrelationship between the content of immunizing units and the immunogenicity of C1. perfringens anatoxins]. Nenashev VP; Akhundova KA Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):93-6. PubMed ID: 173119 [TBL] [Abstract][Full Text] [Related]
18. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea. Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605 [TBL] [Abstract][Full Text] [Related]